What the Allergan/Valeant Story Teaches About Staggered Boards 

The Harvard Law School Forum on Corporate Governance and Financial Regulation 2015-07-24

Summary:

Until March 2015, I was the Executive Vice President and General Counsel of Allergan, Inc. For much of 2014 my job was to address the hostile bid launched by Valeant and Pershing Square to acquire Allergan. With that perspective, I followed with interest the debate surrounding staggered boards, and in particular the success of institutional […]

Link:

http://corpgov.law.harvard.edu/2015/07/24/what-the-allerganvaleant-story-teaches-about-staggered-boards/

From feeds:

Blogs.law Aggregation Hub » The Harvard Law School Forum on Corporate Governance and Financial Regulation

Tags:

board declassification

Authors:

Harvard Law School Forum on Corporate Governance and Financial Regulation

Date tagged:

07/24/2015, 15:30

Date published:

07/24/2015, 09:06